Background/Aims: Metastasis to the stomach is rare. The aim of this study was to describe and analyze the clinical outcomes of @entity5 that metastasized to the stomach. Methods: We reviewed the clinicopathological aspects of @entity1 with gastric metastases from solid organ @entity5 . Thirty-seven cases were identified, and we evaluated the histology, initial presentation, imaging findings, lesion locations, treatment courses, and overall @entity1 survival. Results: Endoscopic findings indicated that solitary lesions presented more frequently than @entity75 and @entity5 were the most common appearance. @entity320 was the @entity5 that most frequently metastasized to the stomach. Twelve @entity1 received treatments after the diagnosis of gastric @entity3 . The median survival period from the diagnosis of gastric @entity3 was 3.0 months (interquartile range, 1.0 to 11.0 months). @entity1 with solitary lesions and @entity1 who received any treatments survived longer after the diagnosis of @entity5 than @entity1 with @entity75 and @entity1 who did not any receive any treatments. Conclusions: Proper treatment with careful consideration of the primary @entity5 characteristics can increase the survival period in @entity1 with @entity5 that metastasize to the stomach, especially in cases with solitary metastatic lesions in endoscopic findings. (Gut Liver, Published online December 5, 2014).

Clinical and Endoscopic Features of XXXX in the Stomach.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cancers', 'metastatic cancer', 'submucosal tumor-like tumors', 'tumors'] @entity75 :: ('MESH:D001927', 'Disease') :: ['multiple lesions'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity320 :: ('MESH:D008545', 'Disease') :: ['Malignant melanoma']
@entity3 :: (MESH:D009362,Disease) :: ['Metastatic Tumors']
